As depicted in Table S1, during the immune cell type analysis, we observed that CD4+ T cells and type‐2 DCs decreased, while CD8+ T cells and plasmacytes significantly increased in all three batches of recurrent bladder tumours, indicating an expected stronger immune response in recurrent tumours. This evidence concerns the gene CD4 and urinary bladder neoplasm.